Cortisol and cortisone determination by disposable pipette extraction (DPX) and ultra-efficient liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) in urine and saliva samples from patients with Parkinson's disease
- PMID: 39327306
- DOI: 10.1007/s00216-024-05557-6
Cortisol and cortisone determination by disposable pipette extraction (DPX) and ultra-efficient liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) in urine and saliva samples from patients with Parkinson's disease
Abstract
Higher serum cortisol levels appear to be associated with stress that can overlap or manifest anxiety, fatigue, depression, and sleep dysfunction. These are common and intrusive non-motor symptoms of Parkinson's disease (PD). Thus, stress has been proposed to mediate Parkinson's disease development, and cortisol has been suggested as a biomarker for the generation of stress-related symptoms in Parkinson's disease. This study describes sensitive and robust disposable pipette extraction (DPX) and ultra-efficient liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) method to determine cortisol and cortisone (as potential endocrine biomarkers for Parkinson's disease) in 24-h urine and saliva samples obtained from Parkinson's disease patients. Important parameters on DPX extraction were optimized to achieve the best extraction recovery and cleanup efficiency. The proposed method was linear from 0.5 (lower limit of quantification) to 500 ng mL-1 for cortisol and from 3.0 (lower limit of quantification) to 500 ng mL-1 for cortisone. To determine whether urinary cortisol and urinary cortisone are adequate as biomarkers to evaluate the level of anxiety in patients suffering from Parkinson's disease, twenty-nine Parkinson's disease patients (18 with anxiety and 11 without anxiety) were selected for urine analysis. Based on the obtained results, 24-h urine samples obtained from Parkinson's disease patients with anxiety had higher cortisone levels than samples obtained from healthy controls. Receiving operating curves (ROC) analysis, which presented the area under the ROC curve (AUC = 0.733), showed that urinary cortisone levels (µg/24-h urine) were sensitive (56.3%) and specific (93.3%) for distinguishing Parkinson's disease patients with anxiety from healthy controls. In terms of salivary results, PD patients' samples taken 30 min after waking up had higher cortisol and cortisone levels than healthy controls, while their samples taken at night had lower cortisol and cortisone levels.
Keywords: Anxiety; Cortisol; Cortisone; Sample preparation; Urine.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.
Similar articles
-
Fast accurate quantification of salivary cortisol and cortisone in a large-scale clinical stress study by micro-UHPLC-ESI-MS/MS using a surrogate calibrant approach.J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Oct 1;1182:122939. doi: 10.1016/j.jchromb.2021.122939. Epub 2021 Sep 11. J Chromatogr B Analyt Technol Biomed Life Sci. 2021. PMID: 34547590
-
Determination of urinary cortisol, cortisone and 6-sulfatoxymelatonin using dilute and shoot ultra-high pressure liquid chromatography-tandem mass spectrometry.J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jan 26;978-979:18-23. doi: 10.1016/j.jchromb.2014.11.016. Epub 2014 Dec 3. J Chromatogr B Analyt Technol Biomed Life Sci. 2015. PMID: 25531866
-
Intraindividual stability of cortisol and cortisone and the ratio of cortisol to cortisone in saliva, urine and hair.Steroids. 2017 Feb;118:61-67. doi: 10.1016/j.steroids.2016.12.008. Epub 2016 Dec 18. Steroids. 2017. PMID: 27998757
-
Determination of cortisol in serum, saliva and urine.Best Pract Res Clin Endocrinol Metab. 2013 Dec;27(6):795-801. doi: 10.1016/j.beem.2013.10.008. Epub 2013 Oct 25. Best Pract Res Clin Endocrinol Metab. 2013. PMID: 24275191 Review.
-
In search of Parkinson's disease biomarkers - is the answer in our mouths? A systematic review of the literature on salivary biomarkers of Parkinson's disease.Neurol Neurochir Pol. 2020;54(1):14-20. doi: 10.5603/PJNNS.a2020.0011. Epub 2020 Jan 31. Neurol Neurochir Pol. 2020. PMID: 32003440
References
-
- Nijakowski K, Owecki W, Jankowski J, Surdacka A. Salivary biomarkers for Parkinson’s disease: a systematic review with meta-analysis. Cells. 2024;13:340. https://doi.org/10.3390/cells13040340 . - DOI - PubMed - PMC
-
- Chagas MHN, Oliveira THGF, Linares IMP, Balarini FB, Chagas NMS, Tumas V, Crippa JAS. Can anxiety increase tremors in patients with Parkinson’s disease? An experimental model. Arch Clin Psychiatry (São Paulo). 2017;44:85–8. https://doi.org/10.1590/0101-60830000000126 . - DOI
-
- Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in diagnosing Parkinson’s disease. Lancet Neurol. 2021;20:385–97. https://doi.org/10.1016/S1474-4422(21)00030-2 . - DOI - PubMed - PMC
-
- van Wamelen DJ, Wan Y-M, Ray Chaudhuri K, Jenner P. Stress and cortisol in Parkinson’s disease. 2020;152:131–56. https://doi.org/10.1016/bs.irn.2020.01.005 .
-
- El-Farhan N, Rees DA, Evans C. Measuring cortisol in serum, urine and saliva – are our assays good enough? Ann Clin Biochem Int J Lab Med. 2017;54:308–22. https://doi.org/10.1177/0004563216687335 . - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical